Related to NextGen Includes Thermo Fisher’s Mass Spec Technology to Its Suite of Biomarker Services

• GNS and Bristol-Myers Squibb to Identify Immuno-Inflammation Biomarkers
  
• GE Healthcare to Provide Customers with On-Site Service and Support for AB Sciex Mass Spec Systems
  
• Merck & Co. and BGI Ink Deal Focused on Biomarkers and Genomic Technologies
  
• Merck Serono Opens Biomarker R&D Lab at Pharmaron’s Facility in Beijing
  
• Fox Chase to Use Silicon Biosystems’ Technology in Studying Circulating Tumor Cells
  
• Investigators Identify CD8 T Cell Transcription Signature that Predicts Prognosis in Crohn's and Ulcerative Colitis
  
• NCI Provides $196K for Labcyte and Canary Center to Develop New Cancer Biomarker System
  
• Labindia Divests Businesses to AB Sciex and Leica
  
• OvaGene Licenses Moffitt’s miRNA Markers for Cancer Assays
  
• Protagen, Bayer HealthCare Ink Autoantibody Biomarker Collaboration
  
• Clarient, Acorn Ally to Standardize Cancer Testing
  
• Ezose, Merck & Co. Ink Diabetes Biomarker Deal
  
• Ventana, Advanced Cell Diagnostics Ally for Automated RNA In Situ Hybridization Assays
  
• Lineagen, Fast Forward Team Up to Develop MS Tests
  
• TrovaGene Gains Rights to Mutations Associated with Chronic Lymphocytic Leukemia
  
• Qiagen and Max Planck to Develop Test to Assess Active TB Risk
  
• Foundation and Sanofi Sign Deal for Cancer Biomarkers and Companion Diagnostics
  
• Qiagen Signs Two Biomarker Deals and Confirms Japanese Okay for EGFR Companion Dx
  
• Evotec, Harvard, and Brigham & Women’s Partner on Kidney Diseases
  
• MDxHealth Awarded CLIA Certification for Irvine Laboratory